Skip to main content

Table 1 Antiproliferative activity of trabectedin and rucaparib in soft-tissue sarcoma cells

From: Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas

Cell line ID

Histology

TP53 status

IC50 Trabectedin (nM)

IC50 rucaparib (μM)

Genomic index

ERCC5 mRNA (relative expression level)

ERCC1 mRNA (relative expression level)

BRCA1 mRNA (relative expression level)

IB114

UPS

WT

0.352

1.488

400

 

+

+

IB115

DDLPS

WT

0.445

1.104

93

 

+

IB111

DDLPS

WT

0.480

1.364

331

+

+

++++

IB133

LMS

Mut

2.64

58.08

328

+

++

 

IB134

LMS

Mut

1.92

40.88

340

 

++

+

IB136

LMS

Mut

1.1

31.35

520

+

+

IB112

LMS

Mut

0.984

29.5

392

  

+

IB128

ExOS

WT

0.546

12.036

40

−−−

−−

93T449

WDLPS

WT

0.869

19.2

ND

ND

ND

ND

  1. UPS undifferentiated pleomorphic sarcoma, DDLPS dedifferentiated liposarcomas, LMS leiomyosarcomas, ExOS extrakeletal osteosarcoma, WDLPS well-differentiated liposarcoma